How to train glioma cells to die: molecular challenges in cell death

Journal of Neuro-Oncology

Volumn 126, Issue 3, 2016, Pages 377-384

  Wojton, Jeffrey ^a,b   Meisen, Walter Hans ^a   Kaur, Balveen ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autophagy; Glioma; Necrosis; Resistance

Indexed keywords

DENDRITIC CELL VACCINE; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; TEMOZOLOMIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; AUTOPHAGY; CANCER RESISTANCE; CANCER SURVIVAL; CELL CYCLE ARREST; CELL DEATH; CELL STRESS; CELL SURVIVAL; DNA DAMAGE; DRUG EFFICACY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; INTRACELLULAR SIGNALING; NECROPTOSIS; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; BRAIN TUMOR; GLIOMA; PATHOLOGY;

APOPTOSIS; BRAIN NEOPLASMS; GLIOMA; HUMANS;

EID: 84956643547     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-1980-1     Document Type: Review

References (60)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109
2. Jiang YG, Peng Y, Koussougbo KS (2011) Necroptosis: a novel therapeutic target for glioblastoma. Med Hypotheses 76(3):350–352
3. Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11(9):621–632
4. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR (2010) The BCL-2 family reunion. Mol Cell 37(3):299–310
5. Cartron PF, Loussouarn D, Campone M, Martin SA, Vallette FM (2012) Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme. Cell Death Dis 3:e421
6. Strik H, Deininger M, Streffer J, Grote E, Wickboldt J, Dichgans J et al (1999) BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radio-chemotherapy. J Neurol Neurosurg Psychiatry 67(6):763–768
7. Qiu B, Wang Y, Tao J, Wang Y (2012) Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells. Oncol Rep 28(1):155–160
8. Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ (1998) Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA 95(10):5724–5729
9. Zhu H, Cao X, Ali-Osman F, Keir S, Lo HW (2010) EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial trans-localization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity. Cancer Lett 294(1):101–110
10. Stegh AH, Kim H, Bachoo RM, Forloney KL, Zhang J, Schulze H et al (2007) Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev 21(1):98–111
11. Stegh AH, Kesari S, Mahoney JE, Jenq HT, Forloney KL, Protopopov A et al (2008) Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA 105(31):10703–10708
12. Stegh AH, Brennan C, Mahoney JA, Forloney KL, Jenq HT, Luciano JP et al (2010) Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor. Genes Dev 24(19):2194–2204
13. Tagscherer KE, Fassl A, Campos B, Farhadi M, Kraemer A, Bock BC et al (2008) Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. Oncogene 27(52):6646–6656
14. Manero F, Gautier F, Gallenne T, Cauquil N, Gree D, Cartron PF et al (2006) The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. Cancer Res 66(5):2757–2764
15. Dodou K, Anderson RJ, Small DA, Groundwater PW (2005) Investigations on gossypol: past and present developments. Expert Opin Investig Drugs 14(11):1419–1434
16. Wagenknecht B, Glaser T, Naumann U, Kugler S, Isenmann S, Bahr M et al (1999) Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ 6(4):370–376
17. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ et al (2002) Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20(4):1063–1068
18. Ziegler DS, Wright RD, Kesari S, Lemieux ME, Tran MA, Jain M et al (2008) Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins. J Clin Investig 118(9):3109–3122
19. Chakravarti A, Zhai GG, Zhang M, Malhotra R, Latham DE, Delaney MA et al (2004) Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23(45):7494–7506
20. Fulda S, Wick W, Weller M, Debatin KM (2002) Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8(8):808–815
21. Wagner L, Marschall V, Karl S, Cristofanon S, Zobel K, Deshayes K et al (2013) Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-kappaB-dependent manner. Oncogene 32(8):988–997
22. Begg AC, Stewart FA, Vens C (2011) Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 11(4):239–253
23. Venur VA, Peereboom DM, Ahluwalia MS (2015) Current medical treatment of glioblastoma. Cancer Treat Res 163:103–115
24. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996
25. Kondo N, Takahashi A, Ono K, Ohnishi T (2010) DNA damage induced by alkylating agents and repair pathways. J Nucleic Acids 2010:543531
26. Weller M, Stupp R, Reifenberger G, Brandes AA, van den Bent MJ, Wick W et al (2010) MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol 6(1):39–51
27. Barazzuol L, Jena R, Burnet NG, Meira LB, Jeynes JC, Kirkby KJ et al (2013) Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma. Radiat Oncol 8:65
28. Lin F, de Gooijer MC, Roig EM, Buil LC, Christner SM, Beumer JH et al (2014) ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy. Clin Cancer Res Off J Am Assoc Cancer Res 20(10):2703–2713
29. Tentori L, Leonetti C, Scarsella M, D’Amati G, Vergati M, Portarena I et al (2003) Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. Clin Cancer Res Off J Am Assoc Cancer Res 9(14):5370–5379
30. Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ et al (2007) ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models. Clin Cancer Res Off J Am Assoc Cancer Res 13(9):2728–2737
31. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27–42
32. Liu EY, Ryan KM (2012) Autophagy and cancer–issues we need to digest. J Cell Sci 125(Pt 10):2349–2358
33. White E, DiPaola RS (2009) The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15(17):5308–5316
34. Fan QW, Cheng C, Hackett C, Feldman M, Houseman BT, Nicolaides T et al (2010) Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal 3(147):ra81
35. Shen J, Zheng H, Ruan J, Fang W, Li A, Tian G et al (2013) Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma. Br J Cancer 109(1):164–171
36. Gammoh N, Lam D, Puente C, Ganley I, Marks PA, Jiang X (2012) Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death. Proc Natl Acad Sci USA 109(17):6561–6565
37. Li Y, Zhu H, Zeng X, Fan J, Qian X, Wang S et al (2013) Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-beta in human glioma cells. Mol Neurobiol 47(3):1000–1010
38. Ge PF, Zhang JZ, Wang XF, Meng FK, Li WC, Luan YX et al (2009) Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells. Acta Pharmacol Sin 30(7):1046–1052
39. Chen Y, Meng D, Wang H, Sun R, Wang D, Wang S, et al (2014) VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells. Neuro Oncol 17(3):407–418
40. Cho HY, Wang W, Jhaveri N, Lee DJ, Sharma N, Dubeau L et al (2014) NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas. Mol Cancer Ther 13(8):2004–2017
41. Curry RC, Dahiya S, Alva Venur V, Raizer JJ, Ahluwalia MS (2015) Bevacizumab in high-grade gliomas: past, present, and future. Expert Rev Anticancer Ther 15(4):387–397
42. Gilbert MR, Sulman EP, Mehta MP (2014) Bevacizumab for newly diagnosed glioblastoma. New Engl J Med 370(21):2048–2049
43. Chinot OL, Wick W, Cloughesy T (2014) Bevacizumab for newly diagnosed glioblastoma. New Engl J Med 370(21):2049
44. Hu YL, DeLay M, Jahangiri A, Molinaro AM, Rose SD, Carbonell WS et al (2012) Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 72(7):1773–1783
45. Golden EB, Cho HY, Jahanian A, Hofman FM, Louie SG, Schonthal AH et al (2014) Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg Focus 37(6):E12
46. Rosenfeld MR, Ye X, Supko JG, Desideri S, Grossman SA, Brem S et al (2014) A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy 10(8):1359–1368
47. Alonso MM, Jiang H, Yokoyama T, Xu J, Bekele NB, Lang FF et al (2008) Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death. Mol Ther 16(3):487–493
48. Zong WX, Thompson CB (2006) Necrotic death as a cell fate. Genes Dev 20(1):1–15
49. Stegh AH, Chin L, Louis DN, DePinho RA (2008) What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator. Cell Cycle 7(18):2833–2839
50. Flannery T, McQuaid S, McGoohan C, McConnell RS, McGregor G, Mirakhur M et al (2006) Cathepsin S expression: an independent prognostic factor in glioblastoma tumours—a pilot study. Int J Cancer J Int Du cancer 119(4):854–860
51. Keerthivasan S, Keerthivasan G, Mittal S, Chauhan SS (2007) Transcriptional upregulation of human cathepsin L by VEGF in glioblastoma cells. Gene 399(2):129–136
52. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B et al (2012) Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 45(6):487–498
53. Melo-Lima S, Celeste Lopes M, Mollinedo F (2014) Necroptosis is associated with low procaspase-8 and active RIPK1 and -3 in human glioma cells. Oncoscience 1(10):649–664
54. Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D (2014) Activation of the NLRP3 inflammasome by proteins that signal for necroptosis. Methods Enzymol 545:67–81
55. Reardon DA, Wucherpfennig KW, Freeman G, Wu CJ, Chiocca EA, Wen PY et al (2013) An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. Expert Rev Vaccines 12(6):597–615
56. Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V et al (2012) NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 48(14):2192–2202
57. Turk B, Turk V (2009) Lysosomes as “suicide bags” in cell death: myth or reality? J Biol Chem 284(33):21783–21787
58. Blomgran R, Zheng L, Stendahl O (2007) Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J Leukoc Biol 81(5):1213–1223
59. Racoma IO, Meisen WH, Wang QE, Kaur B, Wani AA (2013) Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PLoS One 8(9):e72882
60. Boya P, Kroemer G (2008) Lysosomal membrane permeabilization in cell death. Oncogene 27(50):6434–6451